Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
N M AldekhailD S Morrison

Abstract

Orlistat is an effective adjunctive treatment to lifestyle modifications in the treatment of obesity. While the majority of current evidence is on the effect of orlistat in obese patients without diabetes, some studies suggest that patients who are obese and have diabetes mellitus lose more weight and have greater improvements in diabetic outcomes when treated with orlistat plus a lifestyle intervention than when treated by lifestyle interventions alone. The aim of this study was to review the evidence of the effects of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes. A systematic review of randomized controlled trials of orlistat in people with type 2 diabetes reporting diabetes outcomes in studies published between January 1990 and September 2013 was conducted. We searched for articles published in English in MEDLINE and EMBASE. Inclusion criteria included all randomized controlled trials of orlistat carried out on adult participants with a body mass index of 25 kg m(-2) or over diagnosed with type 2 diabetes, which reported weight change and at least one diabetic outcome. A total of 765 articles were identified out of which 12 fulfilled the inclusion criteria. The overall mean weight reduc...Continue Reading

References

Jan 26, 1999·JAMA : the Journal of the American Medical Association·M H DavidsonS B Heymsfield
Feb 22, 2002·The New England Journal of Medicine·Susan Z Yanovski, Jack A Yanovski
Dec 4, 2002·Radiology·Richard M Friedenberg
Dec 28, 2002·Diabetes Care·UNKNOWN American Diabetes Association
Aug 4, 2004·Diabetes, Obesity & Metabolism·B Guy-GrandP Valensi
Sep 24, 2004·Current Medical Research and Opinion·T P DidangelosD T Karamitsos
Jan 19, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Alice Y Y Cheng, I George Fantus
Apr 22, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·C Berne, UNKNOWN Orlistat Swedish Type 2 diabetes Study Group
Feb 23, 2010·International Journal of Surgery·David MoherUNKNOWN PRISMA Group
Apr 28, 2010·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·B PaulweberT Yilmaz
Jun 8, 2012·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·S BirksW Brown
Apr 2, 2013·The Cochrane Database of Systematic Reviews·Andrea SiebenhoferThomas Semlitsch
Aug 28, 2014·BMC Medicine·Naveed Sattar, Jason M R Gill

❮ Previous
Next ❯

Citations

Jan 27, 2016·The Lancet. Diabetes & Endocrinology·Clifford J BaileyAnthony H Barnett
Mar 13, 2016·Archives of Biochemistry and Biophysics·Eleonora CremoniniPatricia I Oteiza
Dec 31, 2015·British Journal of Clinical Pharmacology·Giuseppe DerosaAmirhossein Sahebkar
Jan 20, 2017·Current Diabetes Reports·Joseph M Pappachan, Ananth K Viswanath
Apr 19, 2017·Diabetes, Obesity & Metabolism·Anders GummessonMartin Karpefors
Dec 9, 2017·Pharmaceutical Patent Analyst·Hermann Am Mucke
Aug 10, 2019·International Journal of Clinical Practice·Juan J Gorgojo-MartínezFrancisca Almodóvar-Ruiz
Jan 22, 2020·The Annals of Pharmacotherapy·Hanan KhalilRitin Fernandez
Sep 1, 2016·Expert Review of Endocrinology & Metabolism·Robin L BlackLisa M Chastain
Jul 24, 2020·Indian Journal of Endocrinology and Metabolism·Rajeev ChawlaUNKNOWN RSSDI-ESI Consensus Group
Jan 27, 2019·Current Medicinal Chemistry·Sara PaccosiAstrid Parenti
Apr 25, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Jing KeDong Zhao
Mar 6, 2021·Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology·Vian Ahmed Wasta EsmailMarwan S M Al-Nimer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.